Insider Buying: OneMedNet (NASDAQ:ONMD) Insider Acquires 158,730 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMDGet Free Report) insider Jeffrey Yu bought 158,730 shares of the firm’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was bought at an average price of $0.63 per share, for a total transaction of $99,999.90. Following the completion of the acquisition, the insider directly owned 8,780,410 shares in the company, valued at approximately $5,531,658.30. The trade was a 1.84% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Jeffrey Yu also recently made the following trade(s):

  • On Tuesday, June 16th, Jeffrey Yu acquired 172,414 shares of OneMedNet stock. The shares were purchased at an average cost of $0.58 per share, with a total value of $100,000.12.
  • On Wednesday, April 1st, Jeffrey Yu purchased 903,614 shares of OneMedNet stock. The shares were purchased at an average price of $0.83 per share, for a total transaction of $749,999.62.

OneMedNet Stock Up 7.4%

ONMD opened at $0.60 on Wednesday. The stock has a fifty day moving average of $0.83 and a 200-day moving average of $0.92. The firm has a market capitalization of $32.66 million, a P/E ratio of -12.00 and a beta of 1.12. OneMedNet Corporation has a 12-month low of $0.44 and a 12-month high of $4.22.

OneMedNet (NASDAQ:ONMDGet Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.04) EPS for the quarter. The business had revenue of $0.10 million during the quarter.

Wall Street Analysts Forecast Growth

Several analysts have commented on ONMD shares. Weiss Ratings reissued a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen lowered OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, OneMedNet has a consensus rating of “Sell”.

View Our Latest Stock Analysis on ONMD

Institutional Investors Weigh In On OneMedNet

A number of hedge funds have recently made changes to their positions in ONMD. HRT Financial LP acquired a new position in OneMedNet in the fourth quarter valued at about $32,000. Virtu Financial LLC acquired a new stake in shares of OneMedNet during the fourth quarter worth approximately $48,000. Jane Street Group LLC bought a new position in shares of OneMedNet in the fourth quarter valued at approximately $119,000. State Street Corp raised its stake in shares of OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after acquiring an additional 34,200 shares during the last quarter. Finally, Exencial Wealth Advisors LLC boosted its holdings in shares of OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after acquiring an additional 45,401 shares in the last quarter. Institutional investors and hedge funds own 0.95% of the company’s stock.

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Featured Stories

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.